News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
305,658 Results
Type
Article (10909)
Company Profile (47)
Press Release (294702)
Section
Business (105373)
Career Advice (564)
Deals (18522)
Drug Delivery (18)
Drug Development (25849)
Employer Resources (42)
FDA (6435)
Job Trends (5776)
News (157083)
Policy (11153)
Tag
Academia (638)
Alliances (23639)
Alzheimer's disease (470)
Approvals (6422)
Artificial intelligence (65)
Bankruptcy (134)
Best Places to Work (4381)
Biotechnology (37)
Breast cancer (52)
Cancer (460)
Career advice (486)
Cell therapy (70)
Clinical research (20808)
Collaboration (179)
Compensation (76)
COVID-19 (826)
C-suite (61)
Data (409)
Diabetes (40)
Diagnostics (5858)
Earnings (46248)
Employer resources (43)
Events (47461)
Executive appointments (172)
FDA (6619)
Funding (153)
Gene therapy (42)
GLP-1 (164)
Government (1072)
Healthcare (7453)
Infectious disease (852)
Inflammatory bowel disease (41)
Interviews (64)
IPO (8809)
Job creations (1516)
Job search strategy (449)
Layoffs (146)
Legal (2845)
Lung cancer (57)
Manufacturing (60)
Medical device (5531)
Medtech (5532)
Mergers & acquisitions (9766)
Metabolic disorders (121)
Neuroscience (561)
NextGen Class of 2024 (2291)
Non-profit (1285)
Northern California (716)
Obesity (63)
Opinion (58)
People (30564)
Phase I (6295)
Phase II (8979)
Phase III (7368)
Pipeline (287)
Postmarket research (927)
Preclinical (2478)
Press Release (66)
Radiopharmaceuticals (166)
Rare diseases (58)
Real estate (2550)
Regulatory (7660)
Research institute (714)
Resumes & cover letters (81)
Southern California (540)
Startups (1564)
United States (5874)
Vaccines (80)
Weight loss (40)
Date
Today (58)
Last 7 days (251)
Last 30 days (1690)
Last 365 days (15577)
2024 (14457)
2023 (18121)
2022 (25798)
2021 (26568)
2020 (25166)
2019 (18329)
2018 (14241)
2017 (14539)
2016 (13693)
2015 (17147)
2014 (13395)
2013 (11158)
2012 (11991)
2011 (12617)
2010 (11997)
Location
Africa (310)
Arizona (91)
Asia (15548)
Australia (2546)
California (1464)
Canada (600)
China (58)
Colorado (66)
Connecticut (89)
Europe (37594)
Florida (181)
Georgia (45)
Illinois (139)
Indiana (44)
Japan (41)
Maine (50)
Maryland (191)
Massachusetts (1129)
Michigan (99)
Minnesota (129)
New Jersey (409)
New York (483)
North Carolina (342)
Northern California (716)
Ohio (46)
Pennsylvania (267)
South America (416)
Southern California (540)
Texas (198)
Utah (63)
Washington State (178)
305,658 Results for "roche diagnostics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Roche Buys Poseida for up to $1.5B, Leaning Into Off-the-Shelf CAR T
The acquisition announcement came alongside the reveal of a Phase III failure for Roche’s TIGIT asset tiragolumab, which when combined with Tecentriq did not significantly boost overall survival in non-small cell lung cancer.
November 26, 2024
·
3 min read
·
Tristan Manalac
Policy
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, has received 510 clearance from the United States Food and Drug Administration.
June 18, 2024
·
3 min read
Weight loss
Roche’s Obesity Pill Candidate Hit With Safety Concerns Despite Strong Efficacy Data
When doses were increased rapidly in a Phase I study, patients on Roche’s investigational oral GLP-1 receptor agonist experienced nausea, vomiting, constipation, diarrhea, as well as abdominal distension.
September 12, 2024
·
2 min read
·
Tristan Manalac
Deals
Roche Inks Potential $1.8B Deal With Flare to Target Transcription Factors in Cancer
With $70 million upfront and more than $1.8 billion on the line, Roche will gain access to Flare’s drug discovery engine to bolster its oncology pipeline.
November 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA
November 25, 2024
·
6 min read
Press Releases
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease
October 31, 2024
·
8 min read
Earnings
Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout
Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by strong performance of its multiple sclerosis therapy Ocrevus and eye injection Vabysmo.
October 23, 2024
·
3 min read
·
Tristan Manalac
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
Immunology and inflammation
Roche Looks to Push Gazyva Into Lupus Nephritis With Promising Late-Stage Data
In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis versus placebo, positioning Roche’s therapeutic antibody for expansion into the indication.
September 27, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to work together on new treatments for the neurological disease.
October 22, 2024
·
1 min read
·
Annalee Armstrong
1 of 30,566
Next
